#earningsbeat

[ follow ]
#pfizer #non-covidgrowth #guidanceraise #negativecashflow #risingcapex #margincompression #energystorage
from24/7 Wall St.
3 weeks ago

Pfizer's Q3 Earnings Beat on Top and Bottom Lines

Pfizer beat earnings expectations decisively this morning, posting adjusted EPS of $0.87 against a $0.64 consensus and revenue of $16.65 billion versus $16.50 billion expected. The stock gapped up roughly 12.6% in pre-market trading, reflecting strong investor validation of both the beat and the company's reaffirmed full-year guidance paired with a raised EPS outlook. Management reaffirmed full-year 2025 revenue guidance of $61.0 to $64.0 billion but raised EPS guidance to $3.00 to $3.15 from prior guidance.
Business
Business
from24/7 Wall St.
1 month ago

Whirlpool Stocks Drops After Q3 Earnings

Whirlpool's EPS beat masks weakening fundamentals: declining profits, negative operating and free cash flow, rising capex, and only modest revenue growth.
Business
from24/7 Wall St.
4 weeks ago

Enphase Energy Down 8% After Earnings

Enphase posted a strong Q3 with record battery shipments and a significant beat, but Q4 guidance signals weaker demand, lower revenue, and compressed margins.
from24/7 Wall St.
4 weeks ago

Fortive Corporation Surges Then Comes Back to Earth After Earnings Beat

Fortive's third quarter showed the company making progress on its strategic simplification. Adjusted EBITDA climbed 10.4% year over year to $309M, a meaningful gain that signals operational discipline is taking hold. Revenue came in at $1.027B, beating estimates by $20M on 2.3% year-over-year growth. Within that, Intelligent Operating Systems revenue reached $699M (up 2.6%), while Advanced Healthcare Solutions contributed $328M (up 1.9%). Both segments moved forward despite the company's ongoing portfolio restructuring.
Business
[ Load more ]